Developmental outcome after corpus callosotomy for infants and young children with drug-resistant epilepsy

Area of Science:

• Pediatric Neurology
• Epilepsy Surgery
• Developmental Pediatrics

Background:

• Drug-resistant epilepsy in early childhood often presents with severe developmental impairment.
• Corpus callosotomy (CC) is a surgical option for intractable epilepsy, but its impact on development in young children requires examination.

Purpose of the Study:

• To evaluate the developmental and seizure outcomes following corpus callosotomy (CC) in children under six years old.
• To identify factors associated with developmental improvements after CC in this pediatric population.

Main Methods:

• Retrospective study of 106 patients undergoing CC before age six for drug-resistant epilepsy.
• Developmental outcomes assessed one year post-surgery using the Kinder Infant Development Scale.
• Analysis of preoperative and postoperative developmental quotients (DQ) and seizure status.

Main Results:

• Mean preoperative DQ was 25.0 (SD, 20.8); mean change in DQ one year post-CC was -1.6 (SD, 11.6).
• 42.5% of patients demonstrated a mean DQ increase of 6.5 points (SD, 6.4) one year after CC.
• Factors associated with improved DQ included lower preoperative DQ, developmental gain at 1 month, and postoperative seizure freedom (achieved by 21.7% at 1 year).

Conclusions:

• Corpus callosotomy in infancy and early childhood can lead to developmental improvements in a significant subset of children with drug-resistant epilepsy and developmental impairment.
• Seizure remission, even if transient, plays a crucial role in facilitating developmental progress post-surgery.
• CC represents an effective therapeutic option for improving development in early childhood epilepsy.